{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:15:50Z","timestamp":1793650550402,"version":"4.5.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515220159"],"award-info":[{"award-number":["2023A1515220159"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515230011"],"award-info":[{"award-number":["2021B1515230011"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Key Research and Development Plan of Guangzhou","award":["2024B03J1381"],"award-info":[{"award-number":["2024B03J1381"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372813, 82273074, 82425049"],"award-info":[{"award-number":["82372813, 82273074, 82425049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072627"],"award-info":[{"award-number":["82072627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical high-tech project in Guangzhou region","award":["2024P-GX20"],"award-info":[{"award-number":["2024P-GX20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-05032-2","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:34:31Z","timestamp":1783348471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haorong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feidie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-3323","authenticated-orcid":false,"given":"Mingxin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"3","key":"5032_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10125","key":"5032_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375.","journal-title":"Lancet"},{"issue":"4","key":"5032_CR3","doi-asserted-by":"publisher","first-page":"e14070","DOI":"10.1097\/MD.0000000000014070","volume":"98","author":"CY Wang","year":"2019","unstructured":"Wang CY, Li S. Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China. Med (Baltim). 2019;98(4):e14070.","journal-title":"Med (Baltim)"},{"issue":"1","key":"5032_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"5032_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(5):541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"5032_CR6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology. 2018;154(6):1706\u2013e17181701.","journal-title":"Gastroenterology"},{"issue":"4","key":"5032_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","volume":"3","author":"SY Kim","year":"2017","unstructured":"Kim SY, An J, Lim YS, Han S, Lee JY, Byun JH, et al. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma. JAMA Oncol. 2017;3(4):456\u201363.","journal-title":"JAMA Oncol"},{"issue":"4","key":"5032_CR8","first-page":"Cd013346","volume":"4","author":"A Colli","year":"2021","unstructured":"Colli A, Nadarevic T, Miletic D, Giljaca V, Fraquelli M, \u0160timac D, et al. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2021;4(4):Cd013346.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5032_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1039\/C5AN01884F","volume":"141","author":"E Waidely","year":"2016","unstructured":"Waidely E, Al-Yuobi AR, Bashammakh AS, El-Shahawi MS, Leblanc RM. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. Analyst. 2016;141(1):36\u201344.","journal-title":"Analyst"},{"issue":"6","key":"5032_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ajg.2015.100","volume":"110","author":"TS Chang","year":"2015","unstructured":"Chang TS, Wu YC, Tung SY, Wei KL, Hsieh YY, Huang HC, et al. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. Am J Gastroenterol. 2015;110(6):836\u201344. quiz 845.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5032_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-020-00918-x","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liu Y, Chen J, Shu H, Shen S, Li Y, et al. Autoantibody signature in hepatocellular carcinoma using seromics. J Hematol Oncol. 2020;13(1):85.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"5032_CR12","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/hep.30233","volume":"69","author":"J Choi","year":"2019","unstructured":"Choi J, Kim GA, Han S, Lee W, Chun S, Lim YS. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma. Hepatology. 2019;69(5):1983\u201394.","journal-title":"Hepatology"},{"issue":"2","key":"5032_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71\u201388.","journal-title":"Nat Rev Genet"},{"key":"5032_CR14","doi-asserted-by":"publisher","first-page":"105507","DOI":"10.1016\/j.phrs.2021.105507","volume":"166","author":"N Zheng","year":"2021","unstructured":"Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res. 2021;166:105507.","journal-title":"Pharmacol Res"},{"issue":"6","key":"5032_CR15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31(6):745\u201359.","journal-title":"Ann Oncol"},{"issue":"5","key":"5032_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2018.30","volume":"15","author":"M Widschwendter","year":"2018","unstructured":"Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundstr\u00f6m K, et al. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2018;15(5):292\u2013309.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"5032_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, et al. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med. 2022;20(1):8.","journal-title":"BMC Med"},{"issue":"12","key":"5032_CR18","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","volume":"68","author":"J Cai","year":"2019","unstructured":"Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019;68(12):2195\u2013205.","journal-title":"Gut"},{"issue":"11","key":"5032_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nmat4997","volume":"16","author":"RH Xu","year":"2017","unstructured":"Xu RH, Wei W, Krawczyk M, Wang W, Luo H, Flagg K, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16(11):1155\u201361.","journal-title":"Nat Mater"},{"issue":"9","key":"5032_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167\u201377.","journal-title":"Ann Oncol"},{"issue":"5","key":"5032_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.annonc.2023.02.010","volume":"34","author":"Q Gao","year":"2023","unstructured":"Gao Q, Lin YP, Li BS, Wang GQ, Dong LQ, Shen BY, et al. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies. Ann Oncol. 2023;34(5):486\u201395.","journal-title":"Ann Oncol"},{"issue":"1","key":"5032_CR22","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41467-022-32995-6","volume":"13","author":"ML Stackpole","year":"2022","unstructured":"Stackpole ML, Zeng W, Li S, Liu CC, Zhou Y, He S, et al. Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer. Nat Commun. 2022;13(1):5566.","journal-title":"Nat Commun"},{"issue":"13","key":"5032_CR23","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1073\/pnas.1819799116","volume":"116","author":"C Qu","year":"2019","unstructured":"Qu C, Wang Y, Wang P, Chen K, Wang M, Zeng H, et al. Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy. Proc Natl Acad Sci U S A. 2019;116(13):6308\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"5032_CR24","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","volume":"29","author":"J Zhou","year":"2011","unstructured":"Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29(36):4781\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5032_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","volume":"18","author":"Q Ye","year":"2019","unstructured":"Ye Q, Ling S, Zheng S, Xu X. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Mol Cancer. 2019;18(1):114.","journal-title":"Mol Cancer"},{"issue":"2","key":"5032_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.32308","volume":"76","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang Z, Tang W, Wang X, Liu R, Bao H, et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology. 2022;76(2):317\u201329.","journal-title":"Hepatology"},{"issue":"10","key":"5032_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(10):670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6378","key":"5032_CR28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926\u201330.","journal-title":"Science"},{"issue":"672","key":"5032_CR29","doi-asserted-by":"publisher","first-page":"eabp8704","DOI":"10.1126\/scitranslmed.abp8704","volume":"14","author":"P Wang","year":"2022","unstructured":"Wang P, Song Q, Ren J, Zhang W, Wang Y, Zhou L, et al. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection. Sci Transl Med. 2022;14(672):eabp8704.","journal-title":"Sci Transl Med"},{"issue":"1","key":"5032_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01396-z","volume":"16","author":"T Wu","year":"2023","unstructured":"Wu T, Fan R, Bai J, Yang Z, Qian YS, Du LT, et al. The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis. J Hematol Oncol. 2023;16(1):1.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"5032_CR31","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/hep4.1918","volume":"6","author":"N Lin","year":"2022","unstructured":"Lin N, Lin Y, Xu J, Liu D, Li D, Meng H, et al. A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma. Hepatol Commun. 2022;6(7):1753\u201363.","journal-title":"Hepatol Commun"},{"issue":"4","key":"5032_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000367742","volume":"4","author":"BB Chen","year":"2015","unstructured":"Chen BB, Murakami T, Shih TT, Sakamoto M, Matsui O, Choi BI, et al. Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer. 2015;4(4):215\u201327.","journal-title":"Liver Cancer"},{"issue":"6","key":"5032_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","volume":"5","author":"N Liang","year":"2021","unstructured":"Liang N, Li B, Jia Z, Wang C, Wu P, Zheng T, et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng. 2021;5(6):586\u201399.","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"5032_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","volume":"39","author":"IW Deveson","year":"2021","unstructured":"Deveson IW, Gong B, Lai K, LoCoco JS, Richmond TA, Schageman J, et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat Biotechnol. 2021;39(9):1115\u201328.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"5032_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019;179(2):561\u2013e577522.","journal-title":"Cell"},{"issue":"3","key":"5032_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1572-0241.2006.00443.x","volume":"101","author":"F Farinati","year":"2006","unstructured":"Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol. 2006;101(3):524\u201332.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5032_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-023-01872-1","volume":"22","author":"SC Kim","year":"2023","unstructured":"Kim SC, Kim DW, Cho EJ, Lee JY, Kim J, Kwon C, et al. A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma. Mol Cancer. 2023;22(1):164.","journal-title":"Mol Cancer"},{"key":"5032_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ebiom.2018.03.029","volume":"30","author":"A Oussalah","year":"2018","unstructured":"Oussalah A, Rischer S, Bensenane M, Conroy G, Filhine-Tresarrieu P, Debard R, et al. Plasma mSEPT9: a novel circulating cell-free DNA-based epigenetic biomarker to diagnose hepatocellular carcinoma. EBioMedicine. 2018;30:138\u201347.","journal-title":"EBioMedicine"},{"key":"5032_CR39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2147\/OTT.S51913","volume":"6","author":"Y Inokawa","year":"2013","unstructured":"Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, et al. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther. 2013;6:1417\u201324.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"5032_CR40","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.12998\/wjcc.v10.i7.2072","volume":"10","author":"X Yin","year":"2022","unstructured":"Yin X, Yu H, He XK, Yan SX. Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma. World J Clin Cases. 2022;10(7):2072\u201386.","journal-title":"World J Clin Cases"},{"key":"5032_CR41","doi-asserted-by":"publisher","first-page":"681372","DOI":"10.3389\/fcell.2021.681372","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wei H, Fan L, Fang M, He X, Lu B, et al. CLEC4s as potential therapeutic targets in hepatocellular carcinoma microenvironment. Front Cell Dev Biol. 2021;9:681372.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"5032_CR42","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1172\/JCI93488","volume":"127","author":"FO Enane","year":"2017","unstructured":"Enane FO, Shuen WH, Gu X, Quteba E, Przychodzen B, Makishima H, et al. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. J Clin Invest. 2017;127(9):3527\u201342.","journal-title":"J Clin Invest"},{"issue":"8","key":"5032_CR43","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3346\/jkms.2016.31.8.1215","volume":"31","author":"H Li","year":"2016","unstructured":"Li H, Miao Q, Xu CW, Huang JH, Zhou YF, Wu MJ. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK\/MAPK Pathway. J Korean Med Sci. 2016;31(8):1215\u201323.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"5032_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, et al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79(1):109\u201325.","journal-title":"J Hepatol"},{"issue":"1","key":"5032_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13045-025-01747-6","volume":"18","author":"D Guo","year":"2025","unstructured":"Guo D, Huang A, Sun J, Zhang S, Cheng J, Jiang R, et al. The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study. J Hematol Oncol. 2025;18(1):94.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"5032_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung DC, Gray DM 2nd, Singh H, Issaka RB, Raymond VM, Eagle C, et al. A Cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med. 2024;390(11):973\u201383.","journal-title":"N Engl J Med"},{"issue":"10","key":"5032_CR47","doi-asserted-by":"publisher","first-page":"110100","DOI":"10.1016\/j.celrep.2021.110100","volume":"37","author":"Y Shah","year":"2021","unstructured":"Shah Y, Verma A, Marderstein AR, White J, Bhinder B, Garcia Medina JS, et al. Pan-cancer analysis reveals molecular patterns associated with age. Cell Rep. 2021;37(10):110100.","journal-title":"Cell Rep"},{"issue":"12","key":"5032_CR48","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","volume":"40","author":"A Jamshidi","year":"2022","unstructured":"Jamshidi A, Liu MC, Klein EA, Venn O, Hubbell E, Beausang JF, et al. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell. 2022;40(12):1537\u2013e15491512.","journal-title":"Cancer Cell"},{"key":"5032_CR49","doi-asserted-by":"crossref","unstructured":"Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science 2020, 369(6499).","DOI":"10.1126\/science.abb9601"},{"issue":"1","key":"5032_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13148-023-01585-8","volume":"15","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li J. Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems. Clin Epigenetics. 2023;15(1):168.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"5032_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cancers15020533","volume":"15","author":"C Shen","year":"2023","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers (Basel). 2023;15(2):533.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5032_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.31659","volume":"74","author":"G Hernandez-Meza","year":"2021","unstructured":"Hernandez-Meza G, von Felden J, Gonzalez-Kozlova EE, Garcia-Lezana T, Peix J, Portela A, et al. DNA methylation profiling of human hepatocarcinogenesis. Hepatology. 2021;74(1):183\u201399.","journal-title":"Hepatology"},{"issue":"2","key":"5032_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/jms.6.2.108","volume":"6","author":"B Zhang","year":"1999","unstructured":"Zhang B, Yang B. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen. 1999;6(2):108\u201310.","journal-title":"J Med Screen"},{"issue":"5","key":"5032_CR54","doi-asserted-by":"publisher","first-page":"e1652","DOI":"10.1002\/ctm2.1652","volume":"14","author":"DZ Guo","year":"2024","unstructured":"Guo DZ, Huang A, Wang YC, Zhou S, Wang H, Xing XL, et al. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study. Clin Transl Med. 2024;14(5):e1652.","journal-title":"Clin Transl Med"},{"issue":"1","key":"5032_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13073-023-01238-8","volume":"15","author":"Z Deng","year":"2023","unstructured":"Deng Z, Ji Y, Han B, Tan Z, Ren Y, Gao J, et al. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network. Genome Med. 2023;15(1):93.","journal-title":"Genome Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05032-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:28:44Z","timestamp":1790641724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5032"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05032-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhujiang Hospital of Southern Medical University (2021-KY-013-01). Conducted in adherence to the principles of the Declaration of Helsinki, all participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.Z.1, W.X., Q.Z.2, F.L., Y.S., J.Y., J.X., J.Z., Y.Z., G.W., S.C., F.D., and Y.H. declare employment at Burning Rock Biotech. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All statistical analyses presented in the manuscript were conducted independently by the academic authors, who had full access to the primary raw data and take responsibility for the integrity and accuracy of the results.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"530"}}